Nanotechnology for Gene Therapy:

MSI Synthetic Vector Project

The search for clinically useful genes, anti-sense RNA and other nucleic acid products is a huge challenge in the field of biotechnology. However, even when the most useful have been identified, the safe effective delivery of nucleic acids to their working targets in cells is a equally daunting challenge.

In some scenarios, desirable therapeutic genes are delivered by viral vectors. However this adds the risk of controlling a specially selected or modified virus. By designing purely synthetic vectors based on its ferrite and tripartite technologies, MSI has targeted somatic gene therapy for neurologic disorders.